Viatris Change in Accounts Payable 2010-2025 | VTRS

Viatris change in accounts payable for the twelve months ending June 30, 2025 was $-0.062B, a 106.9% decline year-over-year.

  • Viatris annual change in accounts payable for 2024 was $0.036B, a 88.56% decline from 2023.
  • Viatris annual change in accounts payable for 2023 was $0.315B, a 84.9% increase from 2022.
  • Viatris annual change in accounts payable for 2022 was $0.17B, a 341.76% decline from 2021.

Viatris Change in Accounts Payable 2010-2025 | VTRS

  • Viatris annual change in accounts payable for 2024 was $0.036B, a 88.56% decline from 2023.
  • Viatris annual change in accounts payable for 2023 was $0.315B, a 84.9% increase from 2022.
  • Viatris annual change in accounts payable for 2022 was $0.17B, a 341.76% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$151.4B
CVS Health (CVS)$89.8B
Elevance Health (ELV)$69.8B
Cencora (COR)$58.9B
DiDi Global (DIDIY)$28.4B
Labcorp Holdings (LH)$23.1B
Natera (NTRA)$22B
BioMerieux (BMXMF)$17.6B
EUROFINS SCIENT (ERFSF)$15.7B
ICON (ICLR)$14.6B
Medpace Holdings (MEDP)$13.1B
Solventum (SOLV)$12.6B
CochLear (CHEOY)$12.5B
Revvity (RVTY)$10.6B
Caris Life Sciences,�Inc (CAI)$9.9B
Sonic Healthcare (SKHHY)$9.2B
Avantor (AVTR)$8.8B
Charles River Laboratories (CRL)$7.9B
HealthEquity (HQY)$7.7B
Bausch + Lomb (BLCO)$5.1B
Sotera Health (SHC)$4.6B
BrightSpring Health Services (BTSG)$4.2B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.5B
Surgery Partners (SGRY)$3.1B
Alignment Healthcare (ALHC)$3B
Concentras Parent (CON)$3B
Organon (OGN)$2.4B
Premier (PINC)$2.1B
Progyny (PGNY)$1.9B